
The Mark Foundation for Cancer Research is dedicated to accelerating exciting academic discoveries into new therapies and platforms that will substantially improve outcomes for cancer patients. Currently, there are few options for academic scientists to obtain the resources and know-how to advance drug discovery efforts for promising new cancer targets.
To stem this gap, The Mark Foundation has established the Drug Discovery Award program. Through this program, The Mark Foundation aligns with investigators working to discover and progress a new therapeutic agent into preclinical development, providing not only resources to support post-target validation through early lead development but also the expertise of seasoned biopharma R&D scientists who will advise on activities on the critical path to developing a new therapeutic agent.
Watch a recording of our October 10 webinar on the 2024 Drug Discovery RFP below.
Our 2024 Drug Discovery RFP is now closed. Invitations for full applications will be issued in March 2025.
The Project Concept Letter can be a maximum of 2 pages, including any figures or tables. References may be included on an additional page. The Project Concept Letter must be submitted as a PDF file and contain the following information with headings:
Full applications will be accepted by invitation only, after review of Project Concept Letters. Additional guidelines will be provided to invited applicants. Revenue-sharing terms will apply. Details will be shared upon approval of the project for funding.